Aspira Women’s Health (NASDAQ:AWH – Get Free Report) is expected to be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect Aspira Women’s Health to post earnings of ($0.21) per share and revenue of $3.00 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.
Aspira Women’s Health Stock Down 6.9 %
NASDAQ AWH opened at $0.09 on Wednesday. The company has a market capitalization of $1.56 million, a price-to-earnings ratio of -0.07 and a beta of 1.57. The stock’s 50-day simple moving average is $0.27 and its two-hundred day simple moving average is $0.62. Aspira Women’s Health has a twelve month low of $0.08 and a twelve month high of $3.68.
Wall Street Analysts Forecast Growth
Separately, StockNews.com assumed coverage on Aspira Women’s Health in a report on Sunday, January 12th. They issued a “hold” rating on the stock.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Read More
- Five stocks we like better than Aspira Women’s Health
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How Technical Indicators Can Help You Find Oversold StocksĀ
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Consumer Staples Stocks, Explained
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.